Osborn Williams & Donohoe’s Medpace MEDP Stock Holding History

Osborn Williams & Donohoe’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$514K	Hold	7,000	–	–	0.07%	187
2019 Q4	$588K	Sell	7,000 -6,976	-50%	-$540K	0.06%	209
2019 Q3	$1.18M	Sell	13,976 -125	-0.9%	-$9.45K	0.12%	158
2019 Q2	$922K	Buy	14,101 +3,665	+35%	+$211K	0.1%	175
2019 Q1	$633K	Buy	10,436 +3,436	+49%	+$205K	0.07%	224
2018 Q4	$371K	Hold	7,000	–	–	0.07%	172
2018 Q3	$419K	Sell	7,000 -550	-7%	-$30.1K	0.07%	180
2018 Q2	$325K	Hold	7,550	–	–	0.06%	199
2018 Q1	$264K	Sell	7,550 -500	-6%	-$18.3K	0.05%	201
2017 Q4	$292K	Hold	8,050	–	–	0.05%	195
2017 Q3	$257K	Sell	8,050 -3,200	-28%	-$97.7K	0.05%	193
2017 Q2	$326K	Buy	+11,250	New	+$316K	0.06%	182

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Osborn Williams & Donohoe's MEDP Position: Q1 2020 in Review

Osborn Williams & Donohoe held its Medpace (MEDP) position steady in Q1 2020 at 7,000 shares worth $514K. The position accounts for 0.07% of the portfolio, ranked #187.

Osborn Williams & Donohoe first reported a position in MEDP in Q2 2017 and has held it in 12 quarters since. The position peaked at $1.18M in Q3 2019. 269 funds tracked by Wall St. Rank hold MEDP as of Q1 2020.

Osborn Williams & Donohoe held 7,000 shares of Medpace worth $514K as of Q1 2020.
Osborn Williams & Donohoe left its Medpace share count unchanged in Q1 2020.
Medpace made up 0.07% of Osborn Williams & Donohoe's portfolio in Q1 2020, its #187 holding.
Osborn Williams & Donohoe first reported a position in Medpace in Q2 2017 and has held it in 12 quarters since.
Osborn Williams & Donohoe's Medpace position peaked at $1.18M in Q3 2019.
269 funds tracked by Wall St. Rank held Medpace as of Q1 2020.

Based on Osborn Williams & Donohoe's 13F filing for Q1 2020, filed 4 May 2020.